Grant opportunity

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products (R61/R33)

NHLBI Catalyze phased award for product definition, target identification and validation, and preliminary product or lead series identification.

NIHBiomedical product developmentHLBS
Funder
National Institutes of Health (NIH)
Deadline
Jun 18, 2026
Award
Phased R61/R33 award; see NIH notice for budget guidance
Applicant
Research Team
Discipline
Biomedical Sciences
Region
United States
Posted
May 11, 2026

Call summary

Overview

NHLBI Catalyze phased award for product definition and early product-development work.

Who can apply

  • Eligible institutions and teams under NIH rules.
  • Projects should advance small molecules, biologics, or combination products relevant to HLBS research.

What it supports

  • Target identification and validation, preliminary product definition, and early translational product-development activities.

Funding and duration

Phased R61/R33 award; see NIH notice for budget guidance.

Application deadline

Jun 18, 2026

How to apply

Follow the NIH RFA instructions and submit through the NIH application systems.

Call details

About the opportunity

NHLBI Catalyze phased award for product definition and early product-development work.

National Institutes of Health (NIH) lists this opportunity for Research Team, Biomedical Sciences, United States.

This listing is written for researchers, students, universities, NGOs, research teams, policy professionals and academic institutions searching for Biomedical Sciences grants, fellowships, scholarships, conferences, workshops and funding opportunities in United States contexts.

Eligibility

Eligible institutions and teams under NIH rules.

Projects should advance small molecules, biologics, or combination products relevant to HLBS research.

Funding and benefits

Phased R61/R33 award; see NIH notice for budget guidance.

Themes and supported activities

Target identification and validation, preliminary product definition, and early translational product-development activities.

Deadline and timeline

Application deadline: Jun 18, 2026.

Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.

How to apply

Follow the NIH RFA instructions and submit through the NIH application systems.

Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.